Will sesen bio get FDA approval?
Aug 13 (Reuters) - The U.S. Food and Drug Administration has declined to approve Sesen Bio Inc's lead therapy candidate for a type of bladder cancer, the drug developer said on Friday. reuters.comU.S. FDA declines to approve Sesen Bio's bladder cancer treatment
13 August, 2021 - 11:00pm